Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2025 on Tuesday, November 19, 2024....
Company commits to advancing clinical data for Symplicity™ with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial GALWAY, Ireland and WASHINGTON, Oct. 28, 2024...
Medtronic is so bullish on generative artificial intelligence, its executives say, that every department at the medical-device maker has been asked to come up with ways the technology can boost productivity or improve patient outcomes.
Braydon Wiedeman of Waite Park was in a serious car crash eight years ago. Thanks to a Medtronic spinal cord stimulator and hard work, he is now finding relief.